Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 17601-17650 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03366844
Breast Cancer Study of Preoperative Pembrolizumab + Radiation
PHASE1/PHASE2Active, not recruiting
66 participants
Started: Dec 22, 2017 · Completed: Dec 7, 2030
1 condition2 sponsors1 location
NCT03417115
Breast Cancer Registry Platform
N/AActive, not recruiting
5,000 participants
Started: Dec 22, 2017 · Completed: Apr 30, 2029
1 condition1 sponsor1 location
NCT03298659
iFR Guided Multi-vessel Revascularization During Percutaneous Coronary Intervention for Acute Myocardial Infarction
NAActive, not recruiting
1,146 participants
Started: Dec 21, 2017 · Completed: May 31, 2027
2 conditions5 sponsors1 location
NCT03337009
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
NAActive, not recruiting
1,004 participants
Started: Dec 21, 2017 · Completed: Jun 30, 2024
2 conditions2 sponsors1 location
NCT02931890
Multicentric Randomised Trial for Resectable Gastric Cancer
PHASE2Active, not recruiting
207 participants
Started: Dec 21, 2017 · Completed: Mar 31, 2029
1 condition1 sponsor28 locations
NCT03276832
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
EARLY_PHASE1Active, not recruiting
7 participants
Started: Dec 20, 2017 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT03195777
Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT
NAActive, not recruiting
50 participants
Started: Dec 20, 2017 · Completed: Apr 2, 2026
2 conditions1 sponsor1 location
NCT03424421
Anterior Shoulder Instability Treated with a Semitendinosus Subscapular Sling Procedure
NAActive, not recruiting
15 participants
Started: Dec 20, 2017 · Completed: Aug 30, 2032
2 conditions3 sponsors1 location
NCT03304080
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
PHASE1/PHASE2Active, not recruiting
44 participants
Started: Dec 20, 2017 · Completed: Dec 31, 2026
2 conditions4 sponsors5 locations
NCT03370276
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
PHASE1/PHASE2Active, not recruiting
95 participants
Started: Dec 20, 2017 · Completed: Dec 31, 2025
8 conditions4 sponsors3 locations
NCT03408379
Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN
N/AActive, not recruiting
230 participants
Started: Dec 20, 2017 · Completed: Aug 31, 2028
2 conditions1 sponsor1 location
NCT03271372
Adjuvant Avelumab in Merkel Cell Cancer
PHASE3Active, not recruiting
101 participants
Started: Dec 19, 2017 · Completed: Feb 18, 2029
3 conditions2 sponsors9 locations
NCT03308396
Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer
PHASE1/PHASE2Active, not recruiting
57 participants
Started: Dec 19, 2017 · Completed: Dec 31, 2023
3 conditions3 sponsors5 locations
NCT03075748
Visceral Manifold Study for the Repair of TAAA
NAActive, not recruiting
15 participants
Started: Dec 19, 2017 · Completed: Feb 1, 2027
1 condition3 sponsors2 locations
NCT03299166
Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder
PHASE2/PHASE3Active, not recruiting
426 participants
Started: Dec 19, 2017 · Completed: Mar 31, 2026
1 condition1 sponsor57 locations
NCT03281954
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
PHASE3Active, not recruiting
1,550 participants
Started: Dec 19, 2017 · Completed: Nov 30, 2027
1 condition3 sponsors217 locations
NCT03174275
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
PHASE2Active, not recruiting
39 participants
Started: Dec 19, 2017 · Completed: Feb 2, 2027
6 conditions3 sponsors2 locations
NCT06198920
Fatigue Behavior of Peripheral STENt of the Superficial Femoral Artery
N/AActive, not recruiting
30 participants
Started: Dec 19, 2017 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT02489539
Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
NAActive, not recruiting
175 participants
Started: Dec 19, 2017 · Completed: Dec 31, 2027
1 condition1 sponsor51 locations
NCT03756766
Understanding RSV: Severe Disease and the Long Term Consequences
N/AActive, not recruiting
315 participants
Started: Dec 19, 2017 · Completed: Nov 30, 2026
1 condition3 sponsors2 locations
NCT03395197
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
PHASE3Active, not recruiting
1,054 participants
Started: Dec 18, 2017 · Completed: Jun 30, 2027
1 condition2 sponsors355 locations
NCT03334617
Phase II Umbrella Study of Novel Anti-cancer Agents in Patients With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy
PHASE2Active, not recruiting
527 participants
Started: Dec 18, 2017 · Completed: Sep 11, 2026
1 condition1 sponsor45 locations
NCT03315364
Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy
PHASE2/PHASE3Active, not recruiting
549 participants
Started: Dec 18, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor51 locations
NCT03348748
Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer
EARLY_PHASE1Active, not recruiting
20 participants
Started: Dec 18, 2017 · Completed: Oct 8, 2025
7 conditions1 sponsor1 location
NCT03546972
Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants
NAActive, not recruiting
51 participants
Started: Dec 17, 2017 · Completed: Nov 30, 2026
6 conditions2 sponsors1 location
NCT03412162
Biology, Identity & Opportunity Study
NAActive, not recruiting
400 participants
Started: Dec 16, 2017 · Completed: Dec 31, 2032
3 conditions2 sponsors3 locations
NCT03399799
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
PHASE1Active, not recruiting
279 participants
Started: Dec 16, 2017 · Completed: Mar 30, 2029
1 condition1 sponsor13 locations
NCT03281317
Vasoplegic Syndrome in Cardiac Surgery
N/AActive, not recruiting
1,113 participants
Started: Dec 15, 2017 · Completed: Dec 15, 2024
1 condition1 sponsor1 location
NCT03408080
Open Pilot Trial of BHV-4157
PHASE3Active, not recruiting
24 participants
Started: Dec 15, 2017 · Completed: Dec 15, 2024
6 conditions1 sponsor1 location
NCT03321552
PROMISE International
NAActive, not recruiting
35 participants
Started: Dec 15, 2017 · Completed: Dec 24, 2025
1 condition1 sponsor12 locations
NCT03360994
WATChmAN Virtual Testicular Cancer Clinic
NAActive, not recruiting
144 participants
Started: Dec 15, 2017 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT03326791
Aspirin in Colorectal Cancer Liver Metastases
PHASE2/PHASE3Active, not recruiting
466 participants
Started: Dec 15, 2017 · Completed: Jun 30, 2026
3 conditions4 sponsors14 locations
NCT03371212
A Prospective Randomized Controlled Trial of Dual-Mobility Components in Primary THA
PHASE4Active, not recruiting
52 participants
Started: Dec 15, 2017 · Completed: Dec 1, 2026
1 condition2 sponsors1 location
NCT03315026
Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis
PHASE2Active, not recruiting
30 participants
Started: Dec 14, 2017 · Completed: Oct 31, 2025
2 conditions2 sponsors1 location
NCT03033043
Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection
NAActive, not recruiting
56 participants
Started: Dec 14, 2017 · Completed: Oct 31, 2026
1 condition1 sponsor21 locations
NCT03181256
Early Detection of Lung Cancer
N/AActive, not recruiting
45 participants
Started: Dec 14, 2017 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT03377387
Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
PHASE1/PHASE2Active, not recruiting
34 participants
Started: Dec 13, 2017 · Completed: Dec 31, 2026
1 condition2 sponsors10 locations
NCT03212170
FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer
PHASE2Active, not recruiting
20 participants
Started: Dec 13, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03274258
Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma
PHASE2Active, not recruiting
10 participants
Started: Dec 13, 2017 · Completed: Jul 31, 2027
4 conditions2 sponsors1 location
NCT03386305
Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant
PHASE2/PHASE3Active, not recruiting
35 participants
Started: Dec 13, 2017 · Completed: Dec 31, 2021
1 condition2 sponsors1 location
NCT03266783
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism
PHASE4Active, not recruiting
2,760 participants
Started: Dec 13, 2017 · Completed: Aug 31, 2025
1 condition3 sponsors19 locations
NCT03319628
First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b
PHASE1/PHASE2Active, not recruiting
523 participants
Started: Dec 12, 2017 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT03285412
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer
PHASE2Active, not recruiting
120 participants
Started: Dec 12, 2017 · Completed: Oct 31, 2026
1 condition2 sponsors3 locations
NCT03301506
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
PHASE3Active, not recruiting
500 participants
Started: Dec 12, 2017 · Completed: Nov 30, 2028
1 condition1 sponsor108 locations
NCT03424018
An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia
PHASE3Active, not recruiting
119 participants
Started: Dec 12, 2017 · Completed: Jun 30, 2031
1 condition1 sponsor24 locations
NCT03199300
Investigating Cardiovascular Adverse Events Related to Cancer Treatment
N/AActive, not recruiting
20 participants
Started: Dec 12, 2017 · Completed: Jan 31, 2027
3 conditions1 sponsor1 location
NCT03362060
PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
PHASE1Active, not recruiting
20 participants
Started: Dec 12, 2017 · Completed: Dec 30, 2027
2 conditions2 sponsors3 locations
NCT03362294
Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS
PHASE2Active, not recruiting
30 participants
Started: Dec 11, 2017 · Completed: Sep 30, 2026
1 condition1 sponsor7 locations
NCT03411317
Aortic Stenosis: Determinants of Progression, Severity and Left Ventricular Remodeling
N/AActive, not recruiting
350 participants
Started: Dec 11, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03266874
G7 BiSpherical Acetabular Shell PMCF Study
N/AActive, not recruiting
160 participants
Started: Dec 10, 2017 · Completed: Dec 31, 2031
8 conditions1 sponsor5 locations